Trend
DailyUptrend (starting)
4 hourStrong Bearish
1 hourBearish
15 minStrong Bearish
5 minConsolidating
Daily trend turns down below $2.70
Key levels
Resistance$4.70
Resistance$4.30
Support$3.41
Support$2.99
Latest news & SEC filings
NewsCollPlant's LightSolver unit awarded $1.8M by Israel Innovation Authority
NewsCollPlant says Israel Innovation Authority approved a ~$1.8M grant to its subsidiary LightSolver
NewsCollPlant Proposes Renaming Itself OptiPhi Computing
All CLGN news →CollPlant Biotechnologies makes medical products from recombinant human collagen grown in tobacco plants. Its programs focus on aesthetic medicine and printing tissues and organs in three dimensions, including bioinks and breast implants, as well as wound care products VergenixSTR and VergenixFG. The company is based in Israel and works with partners, distributors, and medical companies around the world.
Based on the company's 20-F filed Mar 26, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CLGN.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$2.48
26
Moat Score
NONE
3/9
Piotroski Score
-13.7
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Rotem Eran | officer | Buy | 510,372 | - | Sep 3, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
360.4%
3yr Revenue CAGR
99.4%
EPS Growth YoY
35.17%
FCF Growth YoY
35.2%
Revenue Trend
STRONG
SEPT Investing tracks real-time dark pool institutional trades for CLGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:53:25 | $3.97 | 1,000 | $$4K | SELL |
| 15:11:46 | $4.20 | 2,388 | $$10K | BUY |
| 15:11:46 | $4.03 | 1,500 | $$6K | SELL |
| 15:03:48 | $4.06 | 1,000 | $$4K | BUY |
| 14:41:09 | $4.19 | 1,350 | $$6K | BUY |
5 dark pool trades shown · $$30K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for CollPlant Biotechnologies Ltd (CLGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CollPlant Biotechnologies Ltd (CLGN) is at $3.96, up 1.41% (+$0.06) at the Nov 11, 2026 close.
Latest CLGN news — Nov 7, 2026: CollPlant's LightSolver unit awarded $1.8M by Israel Innovation Authority · Nov 5, 2026: CollPlant says Israel Innovation Authority approved a ~$1.8M grant to its subsidiary LightSolver
CLGN last reported on Sep 30, 2026: EPS -$1.89 vs -$2.45 expected — a beat of 22.9%.
CLGN does not currently pay a dividend.
CollPlant Biotechnologies Ltd reported $3M of debt and $6M of cash (Dec 31, 2025).
Support: $3.41, $2.99. Resistance: $4.30, $4.70, $9.60.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 7, 2026: CollPlant's LightSolver unit awarded $1.8M by Israel Innovation Authority · Nov 5, 2026: CollPlant says Israel Innovation Authority approved a ~$1.8M grant to its subsidiary LightSolver · Nov 5, 2026: CollPlant Proposes Renaming Itself OptiPhi Computing